Marije M Lowik
Overview
Explore the profile of Marije M Lowik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
497
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Heijden L, Kok M, Zocca P, Jessurun G, Schotborgh C, Roguin A, et al.
Am Heart J
. 2018 Apr;
198:25-32.
PMID: 29653644
Aim: The aim was to compare in a noninferiority trial the efficacy and safety of 2 contemporary drug-eluting stents (DESs): a novel, durable polymer-coated stent versus an established bioabsorbable polymer-coated...
2.
Zocca P, Kok M, Tandjung K, Danse P, Jessurun G, Hautvast R, et al.
JACC Cardiovasc Interv
. 2018 Mar;
11(5):462-469.
PMID: 29519378
Objectives: The study sought to evaluate for the first time the 5-year outcomes after treating an all-comers population with newer-generation cobalt chromium-based Resolute Integrity zotarolimus-eluting stents (ZES) (Medtronic, Santa Rosa,...
3.
von Birgelen C, Kok M, Sattar N, Zocca P, Doelman C, Kant G, et al.
JACC Cardiovasc Interv
. 2018 Feb;
11(5):448-459.
PMID: 29454724
Objectives: This study sought to assess the prevalence and clinical impact of silent diabetes and pre-diabetes in "nondiabetic" percutaneous coronary intervention (PCI) all-comers. Background: Patients with undetected and thus untreated...
4.
van der Heijden L, Kok M, Zocca P, Sen H, Lowik M, Mariani S, et al.
J Am Heart Assoc
. 2018 Feb;
7(3).
PMID: 29382666
Background: Percutaneous coronary intervention (PCI) in patients with previous coronary artery bypass grafting (CABG) is associated with adverse clinical events. Although newer generation drug-eluting stents showed favorable short-term safety profiles,...
5.
Kok M, von Birgelen C, Sattar N, Zocca P, Lowik M, Danse P, et al.
EuroIntervention
. 2018 Jan;
14(9):e1049-e1056.
PMID: 29313817
Aims: It is unclear whether detection of prediabetes (pre-DM) by routine assessment of glycated haemoglobin A1c (HbA1c) and fasting plasma glucose (FPG) among patients undergoing percutaneous coronary intervention (PCI) with...
6.
Zocca P, van der Heijden L, Kok M, Lowik M, Hartmann M, Stoel M, et al.
EuroIntervention
. 2017 Nov;
13(10):1168-1176.
PMID: 29151439
Aims: Acute coronary syndrome (ACS) guidelines have been changed, favouring more potent antiplatelet drugs. We aimed to evaluate the safety and efficacy of a ticagrelor- instead of a clopidogrel-based primary...
7.
van der Heijden L, Kok M, Lowik M, Danse P, Jessurun G, Hartmann M, et al.
Cardiology
. 2017 Apr;
137(4):207-217.
PMID: 28445871
Objective: Limited data is available on the long-term outcome of patients with increased cardiovascular event risk, treated with newer-generation durable polymer drug-eluting stents (DES). Methods: We therefore assessed 3-year follow-up...
8.
von Birgelen C, van der Heijden L, Basalus M, Kok M, Sen H, Louwerenburg H, et al.
JAMA Cardiol
. 2017 Jan;
2(3):268-276.
PMID: 28114618
Importance: Long-term follow-up after a clinical trial of 2 often-used, newer-generation drug-eluting stents (DESs) in a broad patient population is of interest. Comprehensive long-term outcome of eligible nonenrolled patients has...
9.
van der Heijden L, Kok M, Lowik M, Danse P, Jessurun G, Hautvast R, et al.
EuroIntervention
. 2016 Dec;
12(17):2128-2131.
PMID: 27916746
Aims: The aim of this report was to assess the three-year safety and efficacy of implanting newer-generation Resolute Integrity zotarolimus-eluting stents (ZES) versus PROMUS Element everolimus-eluting stents (EES) in all-comers....
10.
von Birgelen C, Kok M, van der Heijden L, Danse P, Schotborgh C, Scholte M, et al.
Lancet
. 2016 Nov;
388(10060):2607-2617.
PMID: 27806902
Background: In patients with coronary artery disease, treated with durable polymer-coated drug-eluting stents, the life-long presence of the polymer might delay arterial healing. Novel very thin strut biodegradable polymer stents,...